Celebrex is the most-prescribed drug for treating arthritis. In the nine months ending in September, worldwide sales of Celebrex more than doubled from the same period a year earlier to $2.29 billion, accounting for 6 percent of Pfizer's total sales of $37.59 billion. |
However, recently, it has been found to increase the risk of heart attack by a factor of 2.5 compared with older nonsteroidal anti-inflammatory drugs (NSAIDs). Common Celebrex side effects include cold-like symptoms (fever, sore throat, sneezing, cough), skin rash, swelling in the extremities. The drug has also been linked to an increase in the risk of heart attacks, strokes, blood clots, liver damage, kidney failure, high blood pressure, and sudden death. |